C olorectal carcinoma (CRC) is the third most common cancer among both men and women and is the third most common cause of cancerrelated deaths in the united states. 1 fortunately, both the incidence of CRC and the associated mortality rate have been decreasing steadily, likely secondary to lifestyle modifications and endoscopic surveillance leading to earlier detection of tumors and precancerous lesions. [1] [2] [3] nonetheless, 20% of patients still present with stage iV disease, and although survival has improved among such patients, median survival remains at ≈14 months. 4, 5 Coupled with resection of the primary tumor and adjuvant therapy, the resection of metastases limited to the lung or liver has been associated with significant improvements in survival. 6, 7 however, other sites of metastatic spread of disease or unresectable tumor burden usually preclude the use of curative surgical resection.
nevertheless, over the past decade, there have been a number of studies demonstrating that resection of a primary colorectal tumor, despite the presence of unresectable metastatic disease, may be associated with improved overall survival. [8] [9] [10] for example, Ruo et al 9 reviewed 209 patients with stage iV CRC from a single institution including both symptomatic and asymptomatic patients and found that patients undergoing resection of their primary tumor had a median survival of 16 months as compared with 9 months for unresected patients. in a larger population-based analysis, tarantino et al 8 investigated 37,793 patients with stage iV CRC in the surveillance, epidemiology, and end Results database between 1998 and 2009 and again demonstrated that primary cancer resection was associated with significant improvements in overall and cancer-specific survival.
unfortunately, population-based analyses have the potential for substantial bias, because it can be difficult to determine that a patient had incurable disease (eg, that metastatic disease was not limited to the liver or lung). Beginning in 2003, the national Cancer Data Base (nCDB) began including a variable to define care as that provided "in an effort to palliate or alleviate symptoms, 11 " which could potentially be used to better ensure that patients are not receiving surgical resection with an intent to cure. therefore, taking into account this variable, we performed an analysis in the nCDB that aimed to examine the association between resection of the primary tumor in unresectable metastatic CRC and survival.
PATIENTS AND METHODS

Data Source
the nCDB is a clinical oncology database collecting information from more than 1500 Committee on Canceraccredited hospitals. 12 Current estimates demonstrate that ≈70% of newly diagnosed cancers within the united states are captured in this database. Collected data include patient demographics and comorbidities, treatment regimens, postoperative length of stay and readmission, and long-term overall survival. approval from the Duke university institutional Review Board was obtained before data analysis.
Patient Population
the nCDB was queried from 2003 to 2006 for patients ≥18 years of age who presented with stage iV adenocarcinoma of the colon and rectum, using International Classification of Diseases for Oncology, 3 rd Edition, topography and histology codes. this time period was selected because these were the only years during which both the palliative care variable and long-term survival were available at the time of analysis. Patients with known resection of metastases at other sites (eg, liver or lung) were excluded (using the "surgery at other site" variable). to ensure that included patients were not receiving therapy with the intention to cure, only patients listed as having undergone surgery, chemotherapy, or radiation as palliative treatment were included in the analysis. to ensure that only patients who had a colonic or rectal resection (and not a surgical biopsy or bypass procedure) were included in the surgery group, the surgical group was limited to patients with surgery of primary site codes 30 to 80 (which included all of the procedures consistent with or more extensive than at least a partial colectomy or rectal resection). any patient who underwent a surgical procedure that could not be classified was also excluded.
Statistical Analysis
Patients were grouped based on palliative resection with surgery (with/without chemotherapy and/or radiation) versus palliation with chemotherapy and/or radiation alone. Groups were compared with regard to baseline characteristics, treatment characteristics, and outcomes. multivariable logistic regression was then performed to identify patient factors associated with undergoing surgical resection of the primary tumor. Variables included in this model were chosen a priori and included age, sex, race, private insurance status (as a surrogate for socioeconomic status), Charlson/Deyo comorbidity index (0 vs 1 vs 2+), academic facility status, and tumor location (rectal vs colon). Continuous variables were plotted against the logit of undergoing surgery to determine linearity. if nonlinear, they were categorized into groups or transformed as appropriate.
to determine the association between palliative surgical resection and overall survival, Kaplan-meier analysis and the log-rank test were performed. follow-up time was begun at the time of diagnosis (and not surgery) to allow for comparison between the surgical and nonsurgical groups. to account for nonrandom treatment selection, a 1:1 nearest-neighbor propensity-matched analysis was performed. Patients were matched based on a priori determined variables, including age, sex, race, private insurance status, Charlson/Deyo comorbidity index, academic center status, and tumor location (rectal vs colon). tumor characteristics, such as size and pathologic grade, could not be included because these results are based on pathologic specimens in the nCDB and therefore were missing among the majority of nonsurgical patients. the success of the match was evaluated via 2 methods. the first involved comparing the variation in propensity score between groups both before and after matching. the second involved comparing the standardized difference between baseline characteristics both before and after the match. after matching, overall survival was again compared using Kaplan-meier methods and the log-rank test. to demonstrate how survival differed by treatment based on tumor location, Kaplanmeier methods were also used to evaluate the association of palliative surgical resection and overall survival among only patients with colon tumors (excluding rectal tumors).
When unadjusted statistical comparisons were made between groups, continuous variables were evaluated with the Wilcoxon rank-sum test whereas categorical variables were evaluated with the χ 2 test or the fisher exact test as appropriate. Complete case analysis was used for all of the adjusted models. a p value of <0.05 was used to define statistical significance. all of the statistical analyses were performed using R version 3.0.1 (R foundation for statistical Computing, Vienna, austria).
RESULTS
a total of 1446 patients met study inclusion criteria, of which 231 (16%) underwent a colectomy or a rectal resection of their primary tumor without undergoing a metastectomy ( fig. 1 ). of the included patients, 586 (40.5%) had rectal tumors whereas 860 (59.5%) had colon tumors. the median time from disease diagnosis to surgery was 12 days (interquartile range, 3-29 days) among patients receiving a colorectal resection. Patients who underwent a colorectal resection were more likely to be women (50.6% vs 43.5%) and were more likely to be of higher socioeconomic status (38.1% of surgical patients had private insurance vs 30.4% of patients in the nonsurgery group) than patients who were treated with palliative chemotherapy and/or radiation therapy alone. Patients who underwent surgical resection were also significantly less likely to have rectal tumors (8.2% vs 46.7%; p < 0.001). all of the other baseline characteristics were similar between groups (table 1). only 6.1% (n = 14) of surgical patients received any radiation therapy as compared with 47.9% (n = 582) of nonsurgical patients (p < 0.01). in contrast, 42.6% (n = 98) of surgical patients received any form of chemotherapy as compared with 66.0% (n = 801) of nonsurgical patients (p < 0.01). median length of stay after surgical resection was 7 days (interquartile range, 5-11 days), and 16.6% (n = 37) of surgical patients were readmitted within 30 days of discharge. thirty-day mortality was 15.2% (n = 35) in the surgical group.
using multivariable logistic regression to determine patient characteristics associated with surgical resection, we found that age >75 years (adjusted oR, 1.60 (95% Ci, 1.05-2.45)) and private insurance status (adjusted oR, 1.68 (95% Ci, 1.18-2.38)) were both associated with a significantly increased odds of receiving a palliative surgical resection of the primary tumor ( fig. 2) . Conversely, having a rectal tumor as compared with a colon tumor was associated with a significantly reduced odds of receiving a palliative surgical resection of the primary tumor (adjusted oR, 0.10 (95% Ci, 0.06-0.17)).
on unadjusted analysis, a noncurative formal colorectal resection was associated with significantly improved long-term survival as compared with receiving only palliative chemotherapy and/or radiation therapy (median survival, 9.2 vs 7.6 months; p < 0.01; fig. 3 ). after propensity matching, all 231 patients in the surgical group were matched with 231 patients in the group that did not undergo a surgical resection. no substantial baseline differences remained between groups. however, surgical resection of the primary tumor remained significantly associated with improved survival (median survival, 9.2 vs 7.3 months; p < 0.01; fig. 4 ). among only patients with colon tumors, palliative surgical resection of the primary tumor was again associated with a significant improvement in overall survival (8.7 vs 6.7 months; p < 0.01; fig. 5 ).
DISCUSSION
Recent advancements in chemotherapeutic agents and more aggressive surgical resection of isolated metastases have helped extend survival for patients with stage iV CRC. nevertheless, the overall prognosis remains poor, with a 5-year survival of only 8% to 20%. 5, 13, 14 in this study, using strict study criteria in an attempt to reduce bias from possibly including patients who underwent a surgical resection with an intent to cure, we have found that overall survival is improved among patients with stage iV CRC who underwent a colorectal resection to resect their primary tumor. furthermore, this association remained even after adjustment, as well as in a subanalysis of only patients with colon cancers.
interestingly, our benefit of only 1 to 2 months is much smaller than that seen in other studies. for instance, Gresham et al 10 demonstrated an improvement in median survival from 7.9 to 17.9 months, whereas Ruo et al 9 demonstrated an improvement in median survival from 9 to 16 months. tarantino et al 8 demonstrated an improvement in survival from between 3 to 7 months to 12 to 20 months depending on the year analyzed. our reduced survival benefit is likely secondary to a patient cohort with more advanced disease, because we only selected patients listed as being treated with "palliative care." on the other hand, some studies have demonstrated that surgical resection of the primary tumor in this patient population is not associated with a significant survival benefit, so it may be that the variation in study results is attributed to a wide distribution of treatment effects across different patient populations. 15, 16 also, we demonstrated a very high 30-day mortality rate associated with surgery in this study, which may indicate that the majority of surgical procedures performed in our analysis were for symptomatic patients, who tend to have much worse postoperative survival rates than patients who have a primary resection for asymptomatic disease. 17 Both of these points demonstrate the importance of careful patient selection when deciding to proceed with surgical resection of the primary tumor in these patients.
although we have demonstrated a survival benefit associated with the resection of the primary tumor in stage iV CRC, we cannot determine the etiology of this association, especially because the nCDB does not contain data regarding cause of death. there are a number of theories that may explain this phenomenon. for instance, it is possible that surgical resection of the primary tumor prevents long-term, potentially fatal complications including obstruction and bleeding. although rates vary, studies have demonstrated that patients with stage iV CRC will eventually require emergent surgical intervention 7% to 20% of the time, and when these emergent interventions are required, they are associated with a substantially higher mortality rate than an elective resection. 9, 17, 18 our findings support this theory, because the survival benefit secondary to resection appears late, after ≈6 months, which may be the time when complications occur requiring emergent surgery. Conversely, it may be that this is when the benefit of surgical resection finally outweighs the increased early mortality related to the operation itself.
unfortunately, the nCDB also does not contain data related to the quality of life after surgical resection of the primary tumor. theoretically, a patient is trading early time healing from the resection for additional survival at a later date, and therefore the initial decrease in quality of life is offset by a late benefit in quality of life. this tradeoff must be weighed on a patient-by-patient basis, and patient preferences should be taken into account when determining whether this procedure should be undertaken. future research should focus on the effects of surgical resection of these tumors on quality of life. the demonstration that patients receiving surgical resection were more likely to have private insurance demonstrates differences in treatment by socioeconomic status seen previously in studies of oncology patients. 19 furthermore, socioeconomic status has been found to be significantly associated with survival among oncology patients. 20, 21 although a more extensive investigation into the etiology of this discrepancy is not possible because of the nature of the nCDB, this finding demonstrates that, even in the absence of a known treatment effect, socioeconomic status is an important determinant of how a patient is treated.
there are a number of limitations to this study that should be mentioned. first, many of the previous studies on this topic have investigated either asymptomatic or symptomatic patients, because these are two very different populations of patients. symptomatic patients are likely to have substantially increased perioperative morbidity and mortality rates than asymptomatic patients. By not being able to differentiate these 2 groups, it is possible that our findings are less applicable to the overall population. second, the nCDB has poor recording of tumor-specific characteristics, such as tumor size and grade. among patients who did not undergo a surgical resection, and therefore we could not adjust for these in our analysis. symptomatic patients are more likely to have larger and more invasive tumors, and therefore the resection group may have a disproportionate number of these tumors. Conversely, patients who did not undergo surgical resection may have had more extensive metastatic disease, limiting their ability to undergo a surgical resection. lastly, as with any retrospective analysis, there is the potential for unobserved confounding and bias, which we could not adjust for in our analysis. for example, it is possible that surgeons were more likely to operate on patients with less disease burden or who had a better functional status at the time of diagnosis, thus biasing our results. nonetheless, this is a potential concern of any retrospective study, and we believe that these results still provide important data for clinical decision making while awaiting the results from prospective clinical trials.
although treatment options for CRC have improved, survival for patients with distant unresectable metastatic disease is still poor. 13, 14 in this study, we have demonstrated that surgical resection of the primary tumor for palliative reasons in stage iV CRC is associated with significant improvements in survival. future research is necessary to determine which patients may benefit from this intervention.
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